RecruitingNCT06711575
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
Sponsor
Shandong University
Enrollment
300 participants
Start Date
Oct 12, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.
Eligibility
Inclusion Criteria1
- Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy.
Exclusion Criteria2
- Pregnant/lactating women.
- There are other factors that the researchers think are not suitable for inclusion
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAnti-Infective Drugs
Anti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06711575